RAPID Feasibility Study: A Pilot Study for the Rapid Infusion of Dinutuximab
Latest Information Update: 05 Nov 2024
At a glance
- Drugs Dinutuximab (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- Acronyms RAPID
Most Recent Events
- 01 Nov 2024 Planned End Date changed from 1 Aug 2024 to 1 Jun 2025.
- 01 Nov 2024 Planned primary completion date changed from 1 Aug 2024 to 1 Jun 2025.
- 01 Nov 2024 Status changed from recruiting to suspended.